Readmission Prevention Pilot Trial in Diabetes Patients

Completed · Not applicable

Conditions studied: Diabetes Mellitus

In brief

Post-discharge hospital utilization, i.e., readmissions within 30 days of discharge (30d readmissions) and emergency department (ED) visits, are a high-priority quality measure and target for cost reduction. Patients with diabetes are disproportionately over-represented in 30d readmissions, especially among racial minorities and urban populations. We have developed and validated a tool, the Diabetes Early Readmission Risk Indicator (DERRI), to predict 30d readmission risk among diabetes patients, which is a critical prerequisite for targeting limited resources for reducing readmission risk to those most in need. Currently, there are no proven interventions to reduce the risk of 30d readmission specifically among patients with diabetes. This proposal will assess the feasibility and acceptability of a novel, multifactorial intervention, the Diabetes Transition of Hospital Care Program (DiaTOHC), designed to reduce post-discharge hospital utilization rates in a pilot randomized controlled trial. The intervention will include inpatient diabetes and discharge education, comprehensive discharge planning and coordination of care, A1c-based adjustment of diabetes therapy, and post-discharge support. Hospitalized patients with diabetes identified as high risk for readmission based on the DERRI will be randomized to the intervention or the control group, which will receive usual care. Such work is highly relevant in the current era of soaring health care costs and national health care reform.

Key facts

Study ID

NCT03243383

Run by

Temple University

People needed

263

Starts

2017-09-07

Expected to finish

2019-10-01

Last updated by the study team

2020-10-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diabetes, defined by pre-admission use of a diabetes-specific medication and/or documentation of the diagnosis in the medical record.

You may not qualify if…

• Age < 18 years at the time of admission
• Female subjects who are pregnant and/or admitted to an obstetric service
• Current or expected admission to a critical care unit
• Binge drinking (5 or more alcoholic drinks for males or 4 or more alcoholic drinks for females on the same day) or drug abuse within 3 months before admission
• Inpatient death
• Transfer to another hospital or subacute facility
• Discharge to hospice or a long-term care facility
• Discharge expected within 12 hours or admission to a short-stay unit
• Lack of access to a phone
• Living more than 30 miles away from Temple University Hospital (TUH)
• Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study

Where it is running

• Temple University Hospital — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.